Ardent is a collaboration between Semefab, iSLI and the SMC and has been specifically created to provide the bridge between a biotechnology idea, and a marketable product, helping biotechnology businesses to grow through innovative work in microelectromechanical systems and nanotechnology.
The company's mission is to bring research and early-stage technology to market or application where it can be used to save energy, improve operational efficiency in industrial processes, provide environmental benefits through alternative energy or cleanup technology, aid in the provision of healthcare services, or simply where it is genuinely innovative.
Open access for industry to a suite of state-of-the-art fabrication and characterisation equipment at BioCity Nottingham, UK. Focussed around the needs of industry for short-term, applications oriented development and assessment of nanotechnology approaches to improving products and processes.
The company provides a wide range of R&D and prototyping services. Core facilities include molecular beam epitaxy wafer growth, electron beam lithography, nano-imprint lithography, reactive ion etching and thin film deposition.